Gregory M Weinhoff insider trades

Open-market stock purchases and sales by Gregory M Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Sep 15, 2015.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +102%.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$3.4M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$2.2M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$119K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$1M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$1.7M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$3.1M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$1.9M
Mar 26, 2026CNTA Centessa Pharmaceuticals plcSold$720K
Mar 26, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Mar 13, 2026CNTA Centessa Pharmaceuticals plcSold$1.6M
Mar 13, 2026CNTA Centessa Pharmaceuticals plcSold$324K
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 1, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$348K

Companies traded

  • CNTA Centessa Pharmaceuticals plc: 1 buy, 20 sales, last Jun 24, 2026
  • AXON Axovant Sciences Ltd: other filings, last Mar 15, 2018

Get free alerts when Gregory M Weinhoff files a new trade →